Comparison between the biochemical properties of plasma chitotriosidase from normal individuals and from patients with Gaucher disease, GM1-gangliosidosis, Krabbe disease and heterozygotes for Gaucher disease

被引:22
|
作者
Wajner, Alessandro
Michelin, Kristiane
Burin, Maira G.
Pires, Ricardo F.
Pereira, Maria Luiza S.
Giugliani, Roberto
Coelho, Janice C. [1 ]
机构
[1] Univ Fed Rio Grande do Sul, ICBS, Dept Bioquim, Porto Alegre, RS, Brazil
[2] Hosp Clin Porto Alegre, Serv Genet Med, Porto Alegre, RS, Brazil
[3] Univ Fed Rio Grande do Sul, Dept Genet IB, Porto Alegre, RS, Brazil
关键词
chitotriosidase; Gaucher disease; GM1-gangliosidosis; Krabbe disease; enzyme kinetics; lysosomal storage diseases;
D O I
10.1016/j.clinbiochem.2006.12.003
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
Objectives: The aim of the present work was to establish the range of chitotriosidase (CT) activity in normal individuals (controls), patients with Gaucher disease (GD), GM1-gangliosidosis (GM1), Krabbe disease (KD) and heterozygotes for Gaucher disease (HG). The kinetics of the enzyme in the five groups was also investigated. Design and methods: Plasma CT activity, as well as K-m, V-max, optimum pH and thermal stability of the enzyme was determined in plasma of controls, GM I, KD, GD and HG subjects. Results: CT activity in GD, GM1 and KD patients was, respectively, around 600-fold, 15-fold and 12-fold greater than in normal individuals. There was no significant difference between CT activity in the HG and the control group. We also demonstrated that all CT kinetic parameters evaluated (optimum pH, K-m, thermal stability) in plasma of GD, KD and GM1 patients were significantly different from those of normal individuals. Regarding to thermal stability, our results show that CT activity in the Control group was more stable than in the other groups. Conclusions: Based on the differences found in the biochemical parameters studied, we presume that the parameters analyzed may be useful in the diagnosis of the Lysosomal Storage Diseases. (c) 2007 Published by The Canadian Society of Clinical Chemists. Published by Elsevier Inc. All rights reserved.
引用
收藏
页码:365 / 369
页数:5
相关论文
共 50 条
  • [31] The Complicated Relationship between Gaucher Disease and Parkinsonism: Insights from a Rare Disease
    Aflaki, Elma
    Westbroek, Wendy
    Sidransky, Ellen
    NEURON, 2017, 93 (04) : 737 - 746
  • [32] GAUCHER DISEASE - ISOLATION AND COMPARISON OF NORMAL AND MUTANT GLUCOCEREBROSIDASE FROM HUMAN SPLEEN TISSUE
    PENTCHEV, PG
    BRADY, RO
    BLAIR, HE
    BRITTON, DE
    SORRELL, SH
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1978, 75 (08) : 3970 - 3973
  • [33] TYPE-1 GAUCHER DISEASE - MOLECULAR, BIOCHEMICAL, AND CLINICAL CHARACTERIZATION OF PATIENTS FROM NORTHERN PORTUGAL
    AMARAL, O
    LACERDA, L
    SANTOS, R
    PINTO, RA
    AERTS, H
    MIRANDA, MCS
    BIOCHEMICAL MEDICINE AND METABOLIC BIOLOGY, 1993, 49 (01): : 97 - 107
  • [34] GALACTOSYLCERAMIDE-LOADING AND LACTOSYLCERAMIDE-LOADING STUDIES IN CULTURED FIBROBLASTS FROM NORMAL INDIVIDUALS AND PATIENTS WITH GLOBOID-CELL LEUKODYSTROPHY (KRABBES DISEASE) AND GM1-GANGLIOSIDOSIS
    KOBAYASHI, T
    SHINNOH, N
    GOTO, I
    KUROIWA, Y
    OKAWAUCHI, M
    SUGIHARA, G
    TANAKA, M
    BIOCHIMICA ET BIOPHYSICA ACTA, 1985, 835 (03) : 456 - 464
  • [35] Management goals for type 1 Gaucher disease: An expert consensus document from the European working group on Gaucher disease
    Biegstraaten, M.
    Cox, T. M.
    Belmatoug, N.
    Berger, M. G.
    Collin-Histed, T.
    Vom Dahl, S.
    Di Rocco, M.
    Fraga, C.
    Giona, F.
    Giraldo, P.
    Hasanhodzic, M.
    Hughes, D. A.
    Iversen, P. O.
    Kiewiet, A. I.
    Lukina, E.
    Machaczka, M.
    Marinakis, T.
    Mengel, E.
    Pastores, G. M.
    Ploeckinger, U.
    Rosenbaum, H.
    Serratrice, C.
    Symeonidis, A.
    Szer, J.
    Timmerman, J.
    Tylki-Szymanska, A.
    Hubshman, M. Weisz
    Zafeiriou, D. I.
    Zimran, A. a
    Hollak, C. E. M.
    BLOOD CELLS MOLECULES AND DISEASES, 2018, 68 : 203 - 208
  • [36] Thrombocytopenia in the Absence of Splenomegaly in Patients with Type 1 Gaucher Disease: A Preliminary Analysis From the ICGG Gaucher Registry
    Rosenbloom, Barry E.
    Kulke, Sarah
    Taylor, John
    Weinreb, Neal J.
    BLOOD, 2011, 118 (21) : 1802 - 1803
  • [37] Multiplex Quantification of Plasma Biomarkers for Patients with Gaucher Disease Type 1
    Menkovic, Iskren
    Boutin, Michel
    Lavoie, Pamela
    Auray-Blais, Christiane
    CURRENT PROTOCOLS, 2023, 3 (02):
  • [38] Reported outcomes of 453 pregnancies in patients with Gaucher disease: An analysis from the Gaucher outcome survey
    Lau, Heather
    Belmatoug, Nadia
    Deegan, Patrick
    Goker-Alpan, Ozlem
    Schwartz, Ida Vanessa D.
    Shankar, Suma P.
    Panahloo, Zoya
    Zimran, Ari
    BLOOD CELLS MOLECULES AND DISEASES, 2018, 68 : 226 - 231
  • [39] Reported outcomes of 453 pregnancies in patients with Gaucher disease: an analysis from the Gaucher Outcome Survey
    Lau, Heather
    Belmatoug, Nadia
    Deegan, Patrick
    Goker-Alpan, Ozlem
    Schwartz, Ida Vanessa D.
    Shankar, Suma P.
    Panahloo, Zoya
    Zimran, Ari
    MOLECULAR GENETICS AND METABOLISM, 2017, 120 (1-2) : S80 - S80
  • [40] GENOTYPIC FEATURES OF 41 PATIENTS WITH GAUCHER DISEASE FROM TURKEY
    Hasanoglu, A.
    Akay, G.
    Ezgu, F.
    Biberoglu, G.
    Tumer, L.
    Okur, I
    Kucukcongar, A.
    Kasapkara, C.
    Polat, M.
    Ciftci, B.
    JOURNAL OF INHERITED METABOLIC DISEASE, 2012, 35 : S98 - S98